24 related articles for article (PubMed ID: 33529758)
1. CircUGGT2 facilitates progression and cisplatin resistance of bladder cancer through nonhomologous end-joining pathway.
Lyu F; Huang S; Yan Z; He Q; Liu C; Cheng L; Cong Y; Chen K; Song Y; Xing Y
Cell Signal; 2024 Jul; 119():111164. PubMed ID: 38583745
[TBL] [Abstract][Full Text] [Related]
2. Achieving highly efficient gene transfer to the bladder by increasing the molecular weight of polymer-based nanoparticles.
Li G; He S; Schätzlein AG; Weiss RM; Martin DT; Uchegbu IF
J Control Release; 2021 Apr; 332():210-224. PubMed ID: 33607176
[TBL] [Abstract][Full Text] [Related]
3. A novel LINC02321 promotes cell proliferation and decreases cisplatin sensitivity in bladder cancer by regulating RUVBL2.
Lu C; Gao H; Li H; Luo N; Fan S; Li X; Deng R; He D; Zhao H
Transl Oncol; 2024 Apr; 45():101962. PubMed ID: 38677015
[TBL] [Abstract][Full Text] [Related]
4. Non-coding RNA transcripts, incredible modulators of cisplatin chemo-resistance in bladder cancer through operating a broad spectrum of cellular processes and signaling mechanism.
Hashem M; Mohandesi Khosroshahi E; Aliahmady M; Ghanei M; Soofi Rezaie Y; Alsadat Jafari Y; Rezaei F; Khodaparast Eskadehi R; Kia Kojoori K; Jamshidian F; Nabavi N; Rashidi M; Hasani Sadi F; Taheriazam A; Entezari M
Noncoding RNA Res; 2024 Jun; 9(2):560-582. PubMed ID: 38515791
[TBL] [Abstract][Full Text] [Related]
5. High-Throughput Mass Spectrometry Analysis of
López-Cortés R; Muinelo-Romay L; Fernández-Briera A; Gil Martín E
J Proteome Res; 2024 Apr; 23(4):1379-1398. PubMed ID: 38507902
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin for cancer therapy and overcoming chemoresistance.
Ranasinghe R; Mathai ML; Zulli A
Heliyon; 2022 Sep; 8(9):e10608. PubMed ID: 36158077
[TBL] [Abstract][Full Text] [Related]
7. DNA Polymerase Theta Plays a Critical Role in Pancreatic Cancer Development and Metastasis.
Smolinska A; Singer K; Golchert J; Smyczynska U; Fendler W; Sendler M; van den Brandt J; Singer S; Homuth G; Lerch MM; Moskwa P
Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077614
[TBL] [Abstract][Full Text] [Related]
8. The Role of Ku70 as a Cytosolic DNA Sensor in Innate Immunity and Beyond.
Sui H; Hao M; Chang W; Imamichi T
Front Cell Infect Microbiol; 2021; 11():761983. PubMed ID: 34746031
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of GP130 signaling sensitizes bladder cancer to cisplatin by impairing Ku70 DNA repair signaling and promoting apoptosis.
He S; Li G; Schätzlein AG; Humphrey PA; Weiss RM; Uchegbu IF; Martin DT
Cell Signal; 2021 May; 81():109931. PubMed ID: 33529758
[TBL] [Abstract][Full Text] [Related]
10. Synergistic inhibition of GP130 and ERK signaling blocks chemoresistant bladder cancer cell growth.
Li X; He S; Tian Y; Weiss RM; Martin DT
Cell Signal; 2019 Nov; 63():109381. PubMed ID: 31374291
[TBL] [Abstract][Full Text] [Related]
11. Glycoprotein-130 Expression Is Associated with Aggressive Bladder Cancer and Is a Potential Therapeutic Target.
Martin DT; Shen H; Steinbach-Rankins JM; Zhu X; Johnson KK; Syed J; Saltzman WM; Weiss RM
Mol Cancer Ther; 2019 Feb; 18(2):413-420. PubMed ID: 30381445
[TBL] [Abstract][Full Text] [Related]
12. A novel small molecule inhibitor of the DNA repair protein Ku70/80.
Weterings E; Gallegos AC; Dominick LN; Cooke LS; Bartels TN; Vagner J; Matsunaga TO; Mahadevan D
DNA Repair (Amst); 2016 Jul; 43():98-106. PubMed ID: 27130816
[TBL] [Abstract][Full Text] [Related]
13. URGCP/URG4 promotes apoptotic resistance in bladder cancer cells by activating NF-κB signaling.
Wu M; Chen J; Wang Y; Hu J; Liu C; Feng C; Zeng X
Oncotarget; 2015 Oct; 6(31):30887-901. PubMed ID: 26429874
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
